Paper Details 
Original Abstract of the Article :
Treatment side effects and associated noncompliance have methodological implications vital to the testing of new drugs. In this paper, we quantify the impact of these factors on sample size requirements in clinical trials. In the Lipid Research Clinics Trial, side effects caused treatment group comp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/10543409408835085

データ提供:米国国立医学図書館(NLM)

When Treatments Don't Go as Planned: The Impact of Noncompliance

Imagine a thirsty camel in the desert, desperately seeking water. But what if the oasis it's heading towards turns out to be a mirage? This study explores the challenges of noncompliance in clinical trials, a phenomenon that can affect the validity of research findings. The researchers examined the impact of treatment side effects and noncompliance on the sample size requirements in clinical trials.

A Mirage in the Desert of Research

The study found that treatment side effects can lead to a significant decrease in patient compliance, impacting the accuracy of the results. This can be particularly problematic when testing new drugs, as it can lead to underestimates of true efficacy. It's like trying to map a desert using an inaccurate compass; the final results will be distorted.

The Importance of Patient Compliance

The study highlights the critical importance of patient compliance in clinical trials. To ensure accurate and reliable results, researchers need to find ways to minimize treatment side effects and encourage patient adherence. This can involve developing more effective treatments, improving patient education, and providing personalized support.

Dr.Camel's Conclusion

Noncompliance is a significant challenge in clinical trials, and this study emphasizes the need for researchers to address this issue. By understanding the factors that contribute to noncompliance and developing strategies to mitigate these challenges, we can ensure that our research results are as accurate and reliable as possible.

Date :
  1. Date Completed 1994-12-19
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

7951277

DOI: Digital Object Identifier

10.1080/10543409408835085

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.